Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q3 2021 Results – Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2021 Results Conference Call November 4, 2021 8:30 AM ET
Company Participants
Matt Roache – Director of Investor Relations
Tom McCourt – Chief Executive Officer
Mike Shetzline – Chief Medical Officer
Jason…

Click here to view the original article.